Sprengelmeyer J T, McDermott R L
Nuclear Medicine Dept., Kaiser Foundation Hospital, West Los Angeles, CA 90034.
J Nucl Med. 1990 Dec;31(12):2034-6.
A 68-yr-old male with agnogenic myeloid metaplasia was given phosphorus-32-colloidal chromic phosphate intrapericardially for the treatment of malignant pericardial effusion. Technetium-99m-sulfur colloid was used to verify catheter placement and to visualize distribution within the pericardium. Estimated dosimetry for this mode of therapy is presented, and it is suggested that pericardial administration of phosphorus-32-colloidal chromic phosphate is the treatment of choice for malignant pericardial effusion.
一名68岁患有特发性骨髓化生的男性接受了心包内注射32磷-胶体磷酸铬治疗恶性心包积液。使用99m锝-硫胶体来确认导管位置并观察其在心包内的分布。本文介绍了这种治疗方式的剂量估算，并表明心包内注射32磷-胶体磷酸铬是治疗恶性心包积液的首选方法。
